Paul VanderLaan

Beth Israel Deaconess Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

andrew field

Adjunct Professor

University of Notre Dame

AUSTRALIA

View details

Daniel Sentana Lledo

Harvard University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul VanderLaan

Research Interests

Explore related searches

Contact this professor

Articles (10)

The 2023 Bethesda System for Reporting Thyroid Cytopathology.

The 2023 Bethesda System for reporting thyroid cytopathology.

Percutaneous Aspiration of Lead-Associated Vegetation During Pacemaker Extraction in a Patient With Polymicrobial Device Infection.

EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors.

Multi-institutional 10-year retrospective review of amoeba diagnosed on cytologic evaluation of anal pap tests: what is the significance?

Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance

A brief review of the WHO reporting system for lung cytopathology.

<i>ALK</i> Deletion Exons 2 to 19: Case Report of a Rare ALK Inhibitor-Responsive Lung Cancer Driver Oncogene.

Leveraging thoughtful quality metric selection for individual and system improvements: the atypical category and use of dashboards

Massive Thymic Hyperplasia Masquerading as Cancer: A Case Report and Review of the Literature.

Collaborators (2)

andrew field

Daniel Sentana Lledo

Make your next move.